If you’ve ever wondered what your GP might tell you about your health, it’s time to start asking, The Verge reports.
If you’re feeling unwell, your GP may be able to prescribe you a dose of a medicine called methotrexate, which is typically prescribed for high blood pressure, high cholesterol and obesity.
Methotrexates are often prescribed for people who have severe joint pain, migraines, or other health problems.
But they also have an anti-inflammatory effect, and can be used to treat people with asthma and allergies.
The company that makes the drug, GlaxoSmithKline, doesn’t sell it on its own, and it’s available over-the-counter only in some countries, like the UK and the US.
The article, written by healthcare reporter John Geddes, says that Glaxos recently stopped selling the drug in Australia.
“They say the drug is no longer available, but it’s not,” Gedds writes.
“You’ll need to go to your local chemist and buy the drug from the same pharmacy where you bought it.”
He explains that the drug has been available in Australia for about five years now, and that the Australian market has been flooded with it.
But the drug isn’t available over the counter yet, and there’s no evidence that people are using it to treat their joint pain.
Gedders says the article has been taken down because it was “offensive and misleading”.
He’s also not sure why Glaxoa didn’t notify GPs about the drug’s availability.
“I’d say they have been too slow to respond, and also, too afraid to give out their names and addresses,” he said.
Glaxonks chief executive James Hinkley said that it had been “inadvertently” mislabelled as a methotresis medication.
“The information in the article is correct, and the generic name of methotretate is not methotroxy.
It is methotroxate,” he told The Australian.
“It is a prescription medicine that is sold in pharmacies.”
The article has sparked outrage in the US, where it sparked a boycott of the drug by some healthcare groups.
The drug has also caused controversy in Australia, where a group of US congresspeople, including Senator Barbara Boxer, have called for a boycott, calling it “dangerous” and a “disgraceful abuse of the American healthcare system”.
Geddys article also sparked a backlash on social media, with people saying that it was a way for a “career politician” to gain attention.
Getha Lee, from the American Medical Association, wrote on Facebook that the article was a “fraud” and “a blatant attempt to influence the US healthcare system.”
“This type of deception and misinformation is not the first time this type of scam has been attempted,” she said.
“We have seen similar stories before in Australia and across the world.”
The US Department of Health said it was aware of the article, and would look into it.
It added that it would continue to monitor the situation closely.
“If the drug methotriptyline is no more available in the United States, it may be reassigned to a more generic formulation in the future,” the department said in a statement.
“While methotrezole is an approved medicine for treating some conditions, the US Food and Drug Administration (FDA) does not recommend methotrxole for the treatment of all medical conditions.”
“The American Medical Board is actively working with the FDA to ensure methotroxole remains on the market,” the statement added.
What you need do is: Have your GP check with your doctor to see if the drug you want is available in your country.